1. Home
  2. INBS vs LCFY Comparison

INBS vs LCFY Comparison

Compare INBS & LCFY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Intelligent Bio Solutions Inc.

INBS

Intelligent Bio Solutions Inc.

HOLD

Current Price

$2.35

Market Cap

7.5M

Sector

Health Care

ML Signal

HOLD

Logo Locafy Limited

LCFY

Locafy Limited

HOLD

Current Price

$2.36

Market Cap

8.3M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
INBS
LCFY
Founded
2016
2009
Country
United States
Australia
Employees
N/A
N/A
Industry
Medical Specialities
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.5M
8.3M
IPO Year
2019
2021

Fundamental Metrics

Financial Performance
Metric
INBS
LCFY
Price
$2.35
$2.36
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
95.8K
7.3K
Earning Date
05-08-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,980,484.00
N/A
Revenue This Year
$778.48
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.54
$2.10
52 Week High
$24.90
$7.75

Technical Indicators

Market Signals
Indicator
INBS
LCFY
Relative Strength Index (RSI) 50.33 38.34
Support Level $2.26 $2.10
Resistance Level $2.45 $2.81
Average True Range (ATR) 0.35 0.12
MACD -0.04 -0.01
Stochastic Oscillator 24.50 5.66

Price Performance

Historical Comparison
INBS
LCFY

About INBS Intelligent Bio Solutions Inc.

Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.

About LCFY Locafy Limited

Locafy Ltd is an Australian company currently focused on commercializing its Software as a Service (SaaS) online marketing technology (Technology), which prominently delivers a cost-effective location-based digital marketing solution for small businesses in the key markets of the USA, Australia and Canada. The company has two operating segments: Publishing and SEO Agency. The company derives the majority of its revenue from license subscription fees and advertising fees. Geographically, the maximum revenue is derived from North America.

Share on Social Networks: